Search

Your search keyword '"Mangia, Alessandra"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Mangia, Alessandra" Remove constraint Author: "Mangia, Alessandra" Database Journals@OVID Remove constraint Database: Journals@OVID
49 results on '"Mangia, Alessandra"'

Search Results

2. The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes

5. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

6. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

8. Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

9. Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

10. Interleukin-28B genetic variants in untreated Italian HCV-infected patients: a multicentre study

12. A P70S Variant of the IFNλ4 Protein Displaying Decreased Activity is Associated with Improved Hepatitis C Virus Clearance and Reduced Hepatic Expression of Interferon-Stimulated Genes: 226

13. An Integrated Safety and Efficacy Analysis of >500 Patients with Compensated Cirrhosis Treated with Ledip-asvir/Sofosbuvir with or without Ribavirin: 82

17. Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

18. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

20. Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

21. Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts

22. High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials

23. Benefit of weight based dosages of Ribavirin (RBV) in combination with PegInterferon (PegIFN) α2a in naïve patients with HCV2 and HCV3: results of an Italian Randomized Controlled Trial, the WRITE study: 1737

28. High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patientʼs outcome

29. Inosine Triphosphatase Genetic Variants Are Protective Against Anemia During Antiviral Therapy for Hcv2/3 But Do Not Decrease Dose Reductions of Rbv Or Increase Svr

35. Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection#

Catalog

Books, media, physical & digital resources